CLPP and cancer: Recent investigations have revealed that ONC201, along with its imipridone analogs ONC206 and ONC212, bind to mitochondrial ClpP as an agonist [18, 19], inhibiting oxidative phosphorylation as a component of its anti-cancer mechanism, eventually leading to apoptosis [12, 20].